---
name: Protheragen
slug: obesityscientific
site: cro
website_domain: obesityscientific.com
summary: Specialized preclinical CRO focused on obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
tagline: End-to-end preclinical CRO specializing in obesity research and anti-obesity therapeutic development.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-06T07:03:27.639Z
services_count: 16
modalities_count: 5
indications_count: 1
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Protheragen

End-to-end preclinical CRO specializing in obesity research and anti-obesity therapeutic development.

Listed on cro.directory.

## Summary

Specialized preclinical CRO focused on obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

## Services

- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Safety Pharmacology
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Specialized & Large-Animal Models
- Target Identification & Validation
- Medicinal Chemistry
- Regulatory Affairs
- Medical Writing
- Clinical Operations
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Pharmacovigilance & Drug Safety

## Modalities

- Small Molecule
- Gene Therapy
- Cell Therapy
- Biologics (Monoclonal Antibodies)
- Peptide

## Indications

- Metabolic

## Long description

Protheragen is a contract research organization dedicated to advancing preclinical research in obesity therapeutics. The company provides an integrated obesity research platform spanning discovery through preclinical testing, with expertise in metabolism, inflammation, and cardiovascular biology.

**Core Preclinical Services:**
- Obesity models that replicate obesity-related conditions
- Pharmacodynamic studies assessing biological effects and mechanisms of action
- Pharmacokinetic studies evaluating drug absorption, distribution, metabolism, and excretion
- Bioanalysis using advanced techniques to quantify drug concentrations in biological samples
- Safety assessment and toxicological evaluation in preclinical models
- Target selection and screening across multiple obesity-related pathways (leptin, GLP-1, MC4R, PPARs, CB1/CB2, and others)

**Therapeutic Modalities Supported:**
- Anti-obesity small molecule drug development
- Gene therapy development
- Cell therapy development
- Antibody therapy development
- Tissue engineering therapy development
- Nanotherapy development

**Regulatory & Clinical Support:**
- Regulatory affairs and submission support
- Clinical development strategy and medical writing
- Early phase clinical pharmacology services
- Clinical operations and trial management
- Data management and biostatistics
- Pharmacovigilance and risk management

Protheragen maintains GLP/GMP compliance and quality control standards to ensure regulatory acceptance of preclinical data. The company emphasizes collaborative, tailored approaches with flexible project management to accelerate client drug development timelines.

## Related companies

- [Frontage Laboratories](/companies/frontagelab) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/frontagelab/obesityscientific)
- [Certara](/companies/certara) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/certara/obesityscientific)
- [WuXi AppTec](/companies/wuxiapptec) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/obesityscientific/wuxiapptec)
- [Premier Research](/companies/premier-research) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/obesityscientific/premier-research)
- [QPS](/companies/qps) (In Vivo PK / PD Studies, Preclinical In Vivo Studies) — [Compare](/compare/obesityscientific/qps)
- [Tigermed](/companies/tigermedgrp) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/obesityscientific/tigermedgrp)
- [Labcorp](/companies/labcorp) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/labcorp/obesityscientific)
- [Altasciences](/companies/altasciences) (In Vivo PK / PD Studies, Preclinical In Vivo Studies) — [Compare](/compare/altasciences/obesityscientific)

_Profile last updated: 2026-10-06T07:03:27.639Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.